Volitionrx (VNRX) Return on Equity (2019 - 2025)
Volitionrx (VNRX) has disclosed Return on Equity for 9 consecutive years, with 0.47% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Equity fell 59.0% year-over-year to 0.47%, compared with a TTM value of 0.47% through Sep 2025, down 59.0%, and an annual FY2024 reading of 1.55%, down 451.0% over the prior year.
- Return on Equity was 0.47% for Q3 2025 at Volitionrx, up from 0.36% in the prior quarter.
- Across five years, Return on Equity topped out at 6.21% in Q4 2023 and bottomed at 23.88% in Q3 2023.
- Average Return on Equity over 5 years is 1.39%, with a median of 0.09% recorded in 2022.
- The sharpest move saw Return on Equity plummeted -2397bps in 2023, then surged 2494bps in 2024.
- Year by year, Return on Equity stood at 0.01% in 2021, then crashed by -25607bps to 2.3% in 2022, then surged by 370bps to 6.21% in 2023, then plummeted by -86bps to 0.87% in 2024, then plummeted by -45bps to 0.47% in 2025.
- Business Quant data shows Return on Equity for VNRX at 0.47% in Q3 2025, 0.36% in Q2 2025, and 0.67% in Q1 2025.